John Leaman

Insider Reports History

Location
555 California Street, Suite 365, San Francisco, CA
Signature
/s/ John Leaman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Leaman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IMPEL PHARMACEUTICALS INC Chief Fin. & Business Officer Common Stock 6.94K $2.01K $0.29 Dec 31, 2022 Direct
IMPEL PHARMACEUTICALS INC Chief Fin. & Business Officer Stock Option (right to buy) 70K Feb 14, 2023 Direct
Traws Pharma, Inc. Director Stock Option (right to purchase) 12.8K Nov 21, 2025 Direct
IMPEL PHARMACEUTICALS INC Chief Fin. & Business Officer Restricted Stock Units (RSUs) 0 Dec 31, 2022 Direct

Insider Reports Filed by John Leaman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRAW Traws Pharma, Inc. Nov 21, 2025 1 $0 4 Nov 25, 2025 Director
TRAW Traws Pharma, Inc. Oct 1, 2025 1 $0 4 Oct 14, 2025 Director
TRAW Traws Pharma, Inc. Oct 1, 2025 0 $0 3 Oct 14, 2025 Director
IMPL IMPEL PHARMACEUTICALS INC Feb 14, 2023 1 $0 4 Feb 16, 2023 Chief Fin. & Business Officer
IMPL IMPEL PHARMACEUTICALS INC Dec 31, 2022 3 -$13.6K 4 Jan 4, 2023 Chief Fin. & Business Officer
IMPL IMPEL NEUROPHARMA INC Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Fin. & Business Officer
IMPL IMPEL NEUROPHARMA INC Oct 19, 2021 1 $0 4 Oct 21, 2021 Chief Fin. & Business Officer
IMPL IMPEL NEUROPHARMA INC Jul 20, 2021 1 $0 4 Jul 26, 2021 Chief Financial Officer